{"id":"W2595209185","doi":"10.1200/jco.2014.32.15_suppl.5062","title":"Efficacy and quality of life (QoL) of cabazitaxel/prednisone (Cbz) in Canadian metastatic castration resistant prostate cancer (mCRPC) patients (pts) with or without prior abiraterone acetate (Abi).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Sanofi (Canada); CancerCare Manitoba; Hôtel-Dieu de Québec; Sunnybrook Health Science Centre; University Health Network; Moncton Hospital; University of Toronto; London Health Sciences Centre; Grand River Hospital; Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Cabazitaxel; Prostate cancer; Internal medicine; Discontinuation; Adverse effect; Neutropenia; Febrile neutropenia; Enzalutamide; Oncology; Surgery; Cancer; Chemotherapy; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004499549,0.00022072,0.0003008787,0.0002085478,0.0003109877,0.0003298586,0.0002363343,0.0001893237,0.001074474],"category_scores_gemma":[0.0008256776,0.00008954629,0.0003862331,0.0003950692,0.0002767731,0.0001600523,0.000166029,0.0004656316,0.00008452087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002393463,"about_ca_system_score_gemma":0.001669911,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09916734,"about_ca_topic_score_gemma":0.1955801,"domain_scores_codex":[0.9998229,0.00003035823,0.000009146596,0.00002032759,0.0000715983,0.00004561668],"domain_scores_gemma":[0.999631,0.00005058815,0.0001113173,0.000009707913,0.00004559536,0.0001516702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0905223,0.005709407,0.6809327,0.0006308486,0.001232039,0.0002445921,0.0005389336,0.002413624,0.01200639,0.0001368816,0.003775463,0.2018568],"study_design_scores_gemma":[0.002080127,0.01909041,0.9754835,0.00002419889,0.0003281645,0.000185451,0.00009604735,0.0008771011,0.0006745557,0.00002500594,0.00112077,0.00001458378],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980002,0.0008849395,0.00002486902,0.0001005586,0.00000543161,0.0000419512,0.0002972337,0.000004770317,0.0006400642],"genre_scores_gemma":[0.9991902,0.0002287537,0.00007697145,0.00003925536,0.000006190314,0.0000121452,0.0002679413,5.967283e-7,0.0001779386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9008327,"threshold_uncertainty_score":0.1971803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.166109656704822,"score_gpt":0.4860665985901908,"score_spread":0.3199569418853688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}